LWM
ALXN

Liberty Wealth Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Liberty Wealth Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8
Closed -$1K – 1261
2021
Q2 		$1K Sell
8
-159
-95% -$27.3K ﹤0.01% 1058
2021
Q1 		$26K Hold
167
– – 0.01% 419
2020
Q4 		$26K Sell
167
-11
-6% -$1.41K 0.01% 416
2020
Q3 		$20K Sell
178
-38
-18% -$4.1K 0.01% 406
2020
Q2 		$24K Buy
216
+27
+14% +$2.87K 0.02% 354
2020
Q1 		$17K Sell
189
-11
-6% -$1.08K 0.01% 387
2019
Q4 		$21K Buy
200
+9
+5% +$963 0.02% 411
2019
Q3 		$19K Sell
191
-12
-6% -$1.35K 0.02% 407
2019
Q2 		$27K Sell
203
-1
-0.5% -$129 0.02% 357
2019
Q1 		$27K Buy
204
+13
+7% +$1.62K 0.02% 302
2018
Q4 		$18K Buy
+191
New +$22.6K 0.01% 346

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return